Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Archive ouverte

Barnes, Daniel | Rookus, Matti | Mcguffog, Lesley | Leslie, Goska | Mooij, Thea | Dennis, Joe | Mavaddat, Nasim | Adlard, Julian | Ahmed, Munaza | Aittomäki, Kristiina | Andrieu, Nadine | Andrulis, Irene | Arnold, Norbert | Arun, Banu | Azzollini, Jacopo | Balmaña, Judith | Barkardottir, Rosa | Barrowdale, Daniel | Benitez, Javier | Berthet, Pascaline | Białkowska, Katarzyna | Blanco, Amie | Blok, Marinus | Bonanni, Bernardo | Boonen, Susanne | Borg, Åke | Bozsik, Aniko | Bradbury, Angela | Brennan, Paul | Brewer, Carole | Brunet, Joan | Buys, Saundra | Caldés, Trinidad | Caligo, Maria | Campbell, Ian | Christensen, Lise Lotte | Chung, Wendy | Claes, Kathleen | Colas, Chrystelle | Collonge-Rame, Marie-Agnès | Cook, Jackie | Daly, Mary | Davidson, Rosemarie | de La Hoya, Miguel | de Putter, Robin | Delnatte, Capucine | Devilee, Peter | Diez, Orland | Ding, Yuan Chun | Domchek, Susan | Dorfling, Cecilia | Dumont, Martine | Eeles, Ros | Ejlertsen, Bent | Engel, Christoph | Evans, D Gareth | Faivre, Laurence | Foretova, Lenka | Fostira, Florentia | Friedlander, Michael | Friedman, Eitan | Frost, Debra | Ganz, Patricia | Garber, Judy | Gehrig, Andrea | Gerdes, Anne-Marie | Gesta, Paul | Giraud, Sophie | Glendon, Gord | Godwin, Andrew | Goldgar, David | González-Neira, Anna | Greene, Mark | Gschwantler-Kaulich, Daphne | Hahnen, Eric | Hamann, Ute | Hanson, Helen | Hentschel, Julia | Hogervorst, Frans | Hooning, Maartje | Horvath, Judit | Hu, Chunling | Hulick, Peter | Imyanitov, Evgeny | Isaacs, Claudine | Izatt, Louise | Izquierdo, Angel | Jakubowska, Anna | James, Paul | Janavicius, Ramunas | John, Esther | Joseph, Vijai | Karlan, Beth | Kast, Karin | Koudijs, Marco | Kruse, Torben | Kwong, Ava | Laitman, Yael | Lasset, Christine | Lazaro, Conxi | Lester, Jenny | Lesueur, Fabienne | Liljegren, Annelie | Loud, Jennifer | Lubiński, Jan | Mai, Phuong | Manoukian, Siranoush | Mari, Véronique | Mebirouk, Noura | Meijers-Heijboer, Hanne | Meindl, Alfons | Mensenkamp, Arjen | Miller, Austin | Montagna, Marco | Mouret-Fourme, Emmanuelle | Mukherjee, Semanti | Mulligan, Anna Marie | Nathanson, Katherine | Neuhausen, Susan | Nevanlinna, Heli | Niederacher, Dieter | Nielsen, Finn Cilius | Nikitina-Zake, Liene | Nogues, Catherine, C. | Olah, Edith | Olopade, Olufunmilayo | Ong, Kai-Ren | O'Shaughnessy-Kirwan, Aoife | Osorio, Ana | Ott, Claus-Eric | Papi, Laura | Park, Sue | Parsons, Michael | Pedersen, Inge Sokilde | Peissel, Bernard | Peixoto, Ana | Peterlongo, Paolo | Pfeiler, Georg | Phillips, Kelly-Anne | Prajzendanc, Karolina | Pujana, Miquel Angel | Radice, Paolo | Ramser, Juliane | Ramus, Susan | Rantala, Johanna | Rennert, Gad | Risch, Harvey | Robson, Mark | Rønlund, Karina | Salani, Ritu | Schuster, Hélène | Senter, Leigha | Shah, Payal | Sharma, Priyanka | Side, Lucy | Singer, Christian | Slavin, Thomas | Soucy, Penny | Southey, Melissa | Spurdle, Amanda | Steinemann, Doris | Steinsnyder, Zoe | Stoppa-Lyonnet, Dominique | Sutter, Christian | Tan, Yen Yen | Teixeira, Manuel | Teo, Soo Hwang | Thull, Darcy | Tischkowitz, Marc | Tognazzo, Silvia | Toland, Amanda | Trainer, Alison | Tung, Nadine | van Engelen, Klaartje | van Rensburg, Elizabeth | Vega, Ana | Vierstraete, Jeroen | Wagner, Gabriel | Walker, Lisa | Wang-Gohrke, Shan | Wappenschmidt, Barbara | Weitzel, Jeffrey | Yadav, Siddhartha | Yang, Xin | Yannoukakos, Drakoulis | Zimbalatti, Dario | Offit, Kenneth | Thomassen, Mads | Couch, Fergus | Schmutzler, Rita | Simard, Jacques | Easton, Douglas | Chenevix-Trench, Georgia | Antoniou, Antonis

Edité par CCSD ; Nature Publishing Group -

International audience. We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and BRCA2 pathogenic variant carriers. Methods: Retrospective cohort data on 18,935 BRCA1 and 12,339 BRCA2 female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort. Results: The ER-negative PRS showed the strongest association with BC risk for BRCA1 carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33], P = 3×10 −72). For BRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36], P = 7×10 −50). HR estimates decreased significantly with age and there was evidence for differences in associations by predicted variant effects on protein expression. The HR estimates were smaller than general population estimates. The high-grade serous PRS yielded the strongest associations with EOC risk for BRCA1 (HR = 1.32 [95% CI 1.25-1.40], P = 3×10 −22) and BRCA2 (HR = 1.44 [95% CI 1.30-1.60], P = 4×10 −12) carriers. The associations in the prospective cohort were similar. Conclusion: Population-based PRS are strongly associated with BC and EOC risks for BRCA1/2 carriers and predict substantial absolute risk differences for women at PRS distribution extremes.

Suggestions

Du même auteur

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Archive ouverte | Rebbeck, Timothy | CCSD

International audience. The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The C...

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Archive ouverte | Lakeman, Inge | CCSD

International audience. Purpose: To evaluate the association between a previously published 313 variant-based breast cancer (BC) polygenic risk score (PRS313) and contralateral breast cancer (CBC) risk, in BRCA1 and...

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Archive ouverte | Fachal, Laura | CCSD

International audience. Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored...

Chargement des enrichissements...